Chimeric antigen receptor (CAR-T) cell therapy is a rapidly growing frontier in cancer research, with Australian biotech ...

CAR-T cell therapy is a breakthrough in cancer immunotherapy. The treatment is available in India at a fraction of the cost abroad. Among the many emerging treatments for cancer, there's one called ...

It is the most common childhood cancer, making up 35% of pediatric cancer cases, but it can affect people of any age. CAR T-cell therapy ... immune cells to stop attacking once the infection ...

whereas many cancer vaccines use up to 20 unique antigens 17. It will be important to evaluate the extent to which SABER can broaden the CD8 + T-cell response by loading multiple peptides into ...

Natural Killer (NK) cells are a vital component of the innate immune system, playing a crucial role in identifying and ...

The results challenge long-standing assumptions about the process called 'T-cell priming'. These new insights have significant ... Apr. 14, 2025 — Most cancer genome studies have focused on ...

Introduction: CAR-T cell therapy, though successful in hematologic malignancies, faces challenges in solid tumors due to limitations of autologous T cells. Cytokine-induced killer (CIK) cells can be ...

Immunotherapy fires up the immune system so that it can fight off the cancer. In one type of immunotherapy (CAR T-cell therapy), doctors remove immune cells from your blood, supercharge them in a ...

The cancer vaccine targets the lymph system and enhances its ability to recruit T cells to eliminate tumors. Here, three T cells (blue) are shown attacking and breaking apart a cancer cell. Credit: Yu ...